PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-87.96%
Negative net income growth while JHX stands at 93.86%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
7.30%
Some D&A expansion while JHX is negative at -2.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-100.97%
Negative yoy deferred tax while JHX stands at 281.22%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-4.76%
Both cut yoy SBC, with JHX at -4.69%. Martin Whitman would view it as an industry shift to reduce stock-based pay or a sign of reduced expansions.
-464.98%
Negative yoy working capital usage while JHX is 412.70%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-434.04%
AR is negative yoy while JHX is 91.39%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-443.95%
Negative yoy inventory while JHX is 8.42%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-1952.85%
Negative yoy AP while JHX is 403.41%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-9.89%
Both reduce yoy usage, with JHX at -136.11%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-33.77%
Both negative yoy, with JHX at -140.37%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-135.43%
Negative yoy CFO while JHX is 43.76%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
3.25%
Lower CapEx growth vs. JHX's 10.57%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
-940.57%
Both yoy lines negative, with JHX at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-142.62%
Negative yoy purchasing while JHX stands at 100.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-100.00%
Both yoy lines are negative, with JHX at -100.00%. Martin Whitman suspects an environment prompting fewer sales or fewer maturities within the niche.
-828.00%
Both yoy lines negative, with JHX at -3126.43%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-182.29%
Both yoy lines negative, with JHX at -4.77%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-37.70%
Both yoy lines negative, with JHX at -35.41%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
100.00%
We slightly raise equity while JHX is negative at -0.98%. John Neff sees competitor possibly preserving share count or buying back shares.
46.04%
We have some buyback growth while JHX is negative at -3.81%. John Neff sees a short-term advantage in boosting EPS unless expansions hamper competitor.